FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Delayed Deutsche Boerse AG 01:23:32 06/06/2024 pm IST | ||
| 5.09 EUR | +0.20% |
|
| Current month | -4.33% | ||
| 1 month | +23.30% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 06/24/06 | 5.09 | +0.20% |
| 05/24/05 | 5.08 | +4.10% |
| 04/24/04 | 4.88 | +1.67% |
| 03/24/03 | 4.8 | -9.60% |
| 31/24/31 | 5.31 | -6.18% |
Delayed Quote Deutsche Boerse AG
Last update June 06, 2024 at 01:23 pm IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SB0QYD |
| ISIN | DE000SB0QYD6 |
| Date issued | 04/06/2020 |
| Strike | 60.62 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 9.01 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.79 € |
|---|---|
| Lowest since issue | 0.63 € |
| Spread | 0.11 € |
| Spread % | 2.12% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.24
USD
Average target price
53.19
USD
Spread / Average Target
+28.99%
- Stock Market
- Certificates
- Certificat
